ダウンロード数: 170

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
16_0523.pdf1.06 MBAdobe PDF見る/開く
タイトル: 前立腺肥大症に対するSH 582の使用経験 --estrogen療法との比較--
その他のタイトル: Clinical experience with SH 582 for prostatic hypertrophy; comparison with estrogen therapy
著者: 寺尾, 尚民  KAKEN_name
小川, 功  KAKEN_name
藤村, 宣夫  KAKEN_name
近藤, 圭介  KAKEN_name
津曲, 一郎  KAKEN_name
宇山, 健  KAKEN_name
金川, 征史郎  KAKEN_name
著者名の別形: Terao, Naotami
Ogawa, Isao
Fujimura, Nobuo
Kondo, Keisuke
Tsumagari, Ishiro
Kanagawa, Seishiro
キーワード: Aged
Caproates/adverse effects/therapeutic use
Estrogens/therapeutic use
Humans
Male
Middle Aged
Pregnanes/adverse effects/therapeutic use
Prostatic Hyperplasia/drug therapy
発行日: Sep-1970
出版者: 京都大学医学部泌尿器科学教室
誌名: 泌尿器科紀要
巻: 16
号: 9
開始ページ: 523
終了ページ: 530
抄録: Twenty-five cases of prostatic hypertrophy aging from 56 to 84 were treated with SH 582 over a period ranging from 10 days to 12 months at weekly doses of 300 mg to 900 mg up to a total of 1200 mg to 27000 mg. Clinical symptoms were improved in 19 (76 %) of 25 cases. Retention of urine was greatly or moderately improved in 16 cases (64 %), and unchanged in 9 cases (36 %), which were almost equal to those obtained with estrogen. Palpation of the prostate demonstrated a mild reduction in size in 10 cases (40 %), but histological investigation revealed no clear evidence of reduction in the size of adenoma. Cystourethrography performed in 11 cases were negative for any appreciable change due to administration of SH 582. Body weight was increased in 4 cases and decreased in 1 case. Pre-existing potency in 6 cases was decreased in 4 cases after administration. Hepatic function examined in 19 cases was within normal limits.
URI: http://hdl.handle.net/2433/121160
PubMed ID: 4097364
出現コレクション:Vol.16 No.9

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。